Parabolic Drugs recently announced its results for the fourth quarter and for the financial year that ended March 31, 2011. Vineet Gupta, director of the company, says he is hopeful that new expansions “will help contribute to further margin expansion.”
first published: May 19, 2011 03:30 pm
A collection of the most-viewed Moneycontrol videos.

Rupee Slide Weighs Heavy As Nifty Tests 25,900| Midcaps See Sharp Cuts| Closing Bell Live

Meesho's Rs 5,421 Cr IPO Kicks Off| Post-IPO Playbook, Profitability Path & More| IPO Watch Live

Can Nifty Hold Above 26,000 Amid Currency Jitters? Meesho IPO Opens | Opening Bell Live

Nifty Struggles Below 26,100 On Weekly F&O Expiry As Rupee Hits New Low| Closing Bell Live
You are already a Moneycontrol Pro user.

